Get started
Author

Lihua Song

Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial
2025 · Yongmei Yin, Ying Fan, et al. · Nature Medicine · 84
Sacituzumab tirumotecan (SKB264/MK-2870) in patients (pts) with previously treated locally recurrent or metastatic triple-negative breast cancer (TNBC): Results from the phase III OptiTROP-Breast01 study.
2024 · Binghe Xu, Yongmei Yin, et al. · Journal of Clinical Oncology · 52
Association between Vitamin D Receptor Gene Polymorphisms and Breast Cancer Risk: A Meta-Analysis of 39 Studies
2014 · Kai Zhang, Lihua Song · PLoS ONE · 50
Results of a phase 1/2 study of sacituzumab tirumotecan in patients with unresectable locally advanced or metastatic solid tumors refractory to standard therapies
2025 · Quchang Ouyang, Jordi Rodon, et al. · Journal of Hematology & Oncology · 37
PDF
Physical symptoms and anxiety and depression in older patients with advanced cancer in China: a network analysis
2024 · Mo Tang, Zhongge Su, et al. · BMC Geriatrics · 28
PDF
The regulatory effect of fermented black barley on the gut microbiota and metabolic dysbiosis in mice exposed to cigarette smoke
2022 · Lingyue Zhong, Lina Qin, et al. · Food Research International · 22
Abstract OT1-03-02: Efficacy and safety of SKB264 for previously treated metastatic triple negative breast cancer in Phase 2 study
2023 · Yongmei Yin, Xinhong Wu, et al. · Cancer Research · 17
Suicidal ideation in advanced cancer patients without major depressive disorder
2022 · Lili Tang, Yi He, et al. · Psycho-Oncology · 17
Association between anxiety, depression, and symptom burden in patients with advanced colorectal cancer: A multicenter cross‐sectional study
2024 · Lili Song, Zhongge Su, et al. · Cancer Medicine · 16
PDF
Sacituzumab tirumotecan (sac-TMT) as first-line treatment for unresectable locally advanced/metastatic triple-negative breast cancer (a/mTNBC): Initial results from the phase II OptiTROP-Breast05 study.
2025 · Yongmei Yin, Quchang Ouyang, et al. · Journal of Clinical Oncology · 14
Relationship between fear of progression and symptom burden, disease factors and social/family factors in patients with stage‐IV breast cancer in Shandong, China
2024 · Qianrun Lu, Qiuyue Liu, et al. · Cancer Medicine · 14
PDF
Redox-responsive nanomedicine of doxorubicin-conjugated poly-L-glutathione oxidized for cancer therapy
2024 · Xiao Duan, Qiang Wang, et al. · Journal of the Taiwan Institute of Chemical Engineers · 12
Dynamic analysis of circulating tumor DNA to predict the prognosis and monitor the treatment response of patients with metastatic triple-negative breast cancer: A prospective study
2023 · Yajing Chi, Mu Su, et al. · eLife · 12
PDF
Modified conjoint fascial sheath suspension for the correction of severe congenital blepharoptosis in pediatric patients at different ages
2022 · Huixing Wang, Zhaochuan Liu, et al. · Frontiers in Pediatrics · 10
PDF
Durable Effect of Pyrotinib and Metronomic Vinorelbine in HER2-Positive Breast Cancer With Leptomeningeal Disease: A Case Report and Literature Review
2022 · Yajing Chi, Mao Shang, et al. · Frontiers in Oncology · 9
PDF
CACA clinical guideline of holistic psychosocial care for cancer patients
2025 · Lili Tang, Shikai Wu, et al. · Holistic Integrative Oncology · 8
PDF
Optimization of 3D Printing Parameters of Polylactic-Co-Glycolic Acid-Based Biodegradable Antibacterial Materials Using Fused Deposition Modeling
2023 · Dandan Dou, Lizhen Wang, et al. · 3D Printing and Additive Manufacturing · 8
PDF
Comparison of endocrine therapy and chemotherapy as different systemic treatment modes for metastatic luminal HER2-negative breast cancer patients —A retrospective study
2022 · Qiuyue Liu, Juan Qiu, et al. · Frontiers in Oncology · 8
PDF
Abstract PS08-08: Updated efficacy and safety of SKB264 (MK-2870) for previously treated metastatic triple negative breast cancer (mTNBC) in Phase 2 study
2024 · Yongmei Yin, Xinhong Wu, et al. · Cancer Research · 7
Survival analysis and nomogram for early-stage occult breast cancer with positive lymph nodes based on the SEER database
2022 · Xiaochu Man, Han Xu, et al. · Annals of Translational Medicine · 7
PDF
Efficacy and safety of pyrotinib combined with albumin‐bound paclitaxel as first‐line treatment for HER2‐positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single‐arm, phase 2 prospective clinical trial
2024 · Xiaochu Man, Jie Huang, et al. · Clinical and Translational Medicine · 6
Effectiveness and Safety of Pyrotinib-Based Therapy in the Treatment of HER2-Positive Breast Cancer Patients with Brain Metastases: A Multicenter Real-World Study
2024 · Jie Huang, Shujuan Sun, et al. · Clinical Breast Cancer · 6
PDF
Abstract GS1-06: A randomized control phase III trial of entinostat, a once weekly, class I selective histone deacetylase inhibitor, in combination with exemestane in patients with hormone receptor positive advanced breast cancer
2022 · Binghe Xu, Qingyuan Zhang, et al. · Cancer Research · 6
Relationships Between Insomnia and Quality of Life in Patients With Advanced Liver Cancer: A Secondary Analysis of a Multicenter Cross‐Sectional Study
2025 · Zimeng Li, Lili Song, et al. · Psycho-Oncology · 5
Genome-wide study of drought tolerance traits in wild jujube
2024 · Jingzu Li, Botao Wang, et al. · BMC Plant Biology · 5
PDF
Works count: 58
Citation count: 499
H-index: 12
I10-index: 14
Year
Topic
Type